4Bode B,Weinstein R,Bell D,et al.Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion:a randomized study in type 1 diabetes.Diabetes Care,2002,25:439-444.
2Ilkova H,Glaser B,Tunckale A,et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.Diabetes Oaie,1997,20:1353-1356.
3Del Prato S,Marchetti P,Bonadonna RC.Phasic insulin release and metabolic regulation in type 2 diabetes.Diabetes,2002,51 (suppl 1):s109 -sl16.
4Sivitz WL.Lipotoxicity and glucotoxicity in type 2 diabetes.Effects on development and progression.Postgrad Med,2001,109:55-59,63-64.
5Ykijarvinen H.Pathogenesis of non-insulin-dependent diabetes mellitus.Lancet,1994,343:91-95.
6Jovanovic L. Rationale for prevention and treatment of postprandial glucose-mediated toxicity[J]. Endocrinologist,1999;9:87.
7Heinemann L. Variability of insulin absorption and insulin action[J ]. Diabetes Technol Ther,2002 ;4:673.
8Koya D,King GL. Protein kinase C activation and development of diabetic complications[J]. Diabetes, 1998;47:859.
9Edmond AR,Sharleen 1,Clarissa W.Short Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes[J].Diabetes Care,2004,27:1028-1032.
10Christiansen JS,Vaz JA,Metelko Z,et al.Twice daily biphasic insulin as part improves post prandial glycaemic control more efectively than twice daily NPH insulin with low risk of hypoglycaemia in patients with type 2 diabetes[J].Diabetes Obes Metab,2003,5(6):446-454.
1Khutsomle D, Sharma SK, Almustafa M, et al. Biphasie insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study[ J]. Diabetes Obes Metab ,2008,10 (3) :212-222.
2Christiansen JS, Vaz JA, Metelko Z,et al. Twice daily biphasie insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin ,with low risk of hypoglycaemia, in patients with type 2 diabetes [J]. Diabetes Obes Metab,2003,5(6) : 446-454.
